Equipment & Product Range to Stock

A gynaecology equipment business lives or dies on its catalogue. Before you model a single number, you need to decide which product families you carry, because each one has a different buy price, margin, and sales cycle. A distributor supplying private women's-health clinics carries a very different mix from one chasing hospital theatre contracts. The list below is the procurement backbone your plan should cost out line by line — the prices are typical wholesale/trade guide ranges, not retail list prices.

• Colposcopes (optical & video): $3,000–$18,000 each. The colposcope segment alone was worth around $410 million in 2024 and is forecast to reach $537 million by 2030, so this is a repeatable, defensible line.
• Gynaecology examination tables & chairs (manual and electric): $1,200–$9,500. Electric hi-lo tables with stirrups sell into both NHS and private clinics.
• Hysteroscopy sets & rigid hysteroscopes: $6,000–$32,000 per set. High-value, service-heavy, and where diagnostic-imaging demand is growing fastest.
• Ultrasound systems with transvaginal probes: $12,000–$85,000. Often the single biggest capital line in any one order.
• Cryotherapy & LEEP/electrosurgery units: $2,500–$14,000, plus recurring electrode and consumable sales.
• Handheld instruments & disposables: specula, biopsy forceps, IUD insertion kits, tenacula — low unit price, high volume, and the glue that keeps clinics ordering monthly.
• Sterilisation & storage: autoclaves, instrument trays and trolleys — often bundled to raise average order value.

The strategic point most first-time suppliers miss: the disposables and consumables line looks trivial next to a $60,000 ultrasound, but it is what produces predictable monthly cash flow and keeps you front-of-mind when the clinic finally buys capital equipment. Your business plan should show both the capital-sale funnel and the recurring consumables annuity, because a lender reading the plan wants to see revenue that does not depend on landing a whale every quarter.

What It Costs to Launch

Starting a gynaecology equipment business usually needs $95,000 to $650,000 in the US, or £75,000 to £515,000 in the UK. The spread is wide because it depends almost entirely on which end of the market you enter. A lean regional distributor that drop-ships and holds a small demo fleet can open near the bottom of that range. A business that manufactures or private-labels its own Class II devices, and therefore carries 510(k) or UKCA conformity costs plus real inventory, sits at the top.

Cost Breakdown

• Opening inventory & demo units: $40,000–$260,000 (£32K–£205K). Colposcopes, exam tables, ultrasound and hysteroscopy sets — the biggest single driver.
• FDA establishment registration + state distributor licences (US): $8,000–$25,000, including surety bonds and legal setup.
• MHRA registration + UKCA / UK Responsible Person setup (UK): £300–£6,000 depending on device families and whether you represent overseas makers.
• Warehouse or clean showroom lease & fit-out: $15,000–$120,000 (£12K–£95K).
• Product & professional liability insurance: $6,000–$20,000/yr (£4K–£15K/yr) — non-negotiable for medical devices.
• Website, catalogue, sales collateral & trade-show presence: $8,000–$40,000 (£6K–£30K).
• Working capital (6 months): $18,000–$185,000 (£15K–£165K) to bridge the long clinical procurement cycle.

Funding Routes

In the US, the SBA 7(a) loan is the workhorse for equipment distributors — up to $5 million over terms as long as 10 years for working capital and 25 years for real estate. Because medical devices are capital-heavy, many operators also pair it with equipment financing that secures the loan against the demo fleet itself. Our bespoke plans are formatted with the SBA-compliant financial statements lenders expect. In the UK, the government-backed Start Up Loan offers up to £25,000 per founder at 6% fixed with free mentoring, and asset finance is widely used to fund the demo inventory. Similar routes exist through BDC in Canada and export-credit schemes for cross-border device supply. Whatever the source, the plan needs a believable path to repayment — not a hockey-stick chart.

Who You Buy From: Named Suppliers

The competitive map for a new supplier is really a supply map. You are almost never inventing devices; you are securing distribution rights, dealer terms, or private-label arrangements with the companies that already dominate the category. Knowing who they are — and how a small distributor fits alongside them — is a section every investor and lender flags for.

• Hologic — a category leader in uterine health, hysteroscopy (the Omni hysteroscope line) and cervical screening. Strong brand pull with private clinics.
• CooperSurgical — broad women's-health portfolio spanning IUDs, fertility and office gynaecology instruments; a common anchor line for distributors.
• Karl Storz — Tuttlingen-based endoscopy specialist with a deep rigid-hysteroscopy and laparoscopy range for gynaecology theatres.
• Richard Wolf — another German endoscopy maker frequently ranked among the top gynaecological device companies.
• Medtronic and Boston Scientific — scaled players whose energy, ablation and minimally-invasive lines round out a serious catalogue.

Where does a new entrant win against names like these? Not on price against a global manufacturer, and not on breadth. New distributors win on responsiveness, on genuine clinical service — install, calibrate, train, repair — and on serving a niche the majors treat as an afterthought, such as a single region's private colposcopy clinics. Your plan should name the two or three supplier relationships you intend to build first, the terms you expect, and the service gap you will fill. That is far more convincing than a page insisting you will "disrupt" a $10-billion category.

Registration, Licensing & Compliance

This is the section that separates a credible medical-device plan from a hobby project. You cannot place gynaecology equipment on the market until you have cleared the right registrations, and lenders know it. Build the timeline and the fees into the plan from day one — treating compliance as an afterthought is the fastest way to stall a launch.

United States

• FDA establishment registration & device listing under 21 CFR Part 807. The base annual establishment registration fee is $7,575 for FY2026 and must be renewed every year, per the FDA MDUFA fee schedule.
• 510(k) premarket notification if you manufacture or private-label your own Class II devices. Typical preparation runs $30,000–$44,000 all-in, and complex submissions can reach $50,000–$250,000+.
• State wholesale distributor licences, surety bonds, and Unique Device Identification (UDI) labelling with GUDID entries. Requirements and cost vary sharply state to state.

United Kingdom

• MHRA device registration under the UK Medical Device Regulations 2002. The current fee is £261 per application covering up to 100 device families, effective 16 July 2025, per Emergo by UL; from 1 April 2026 this moves to a recurring annual fee of roughly £300 per GMDN category.
• UKCA marking for devices placed on the Great Britain market.
• UK Responsible Person — mandatory if you distribute for a manufacturer based outside the UK; they handle MHRA communications and registration.
• Registration is a notification process (usually cleared in 1–5 business days), not a safety validation — so your quality system still has to stand on its own.

European Union

• CE marking under the Medical Device Regulation (EU) 2017/745 (MDR), with notified-body conformity assessment for most Class IIa and higher gynaecology devices.
• EUDAMED registration and an EU Authorised Representative for manufacturers based outside the Union.

If you plan to sell across the US, UK and EU, budget for three parallel registration tracks and stagger them in the launch timeline. A plan that pretends one clearance opens every market is the first thing an experienced device investor will challenge.

How the Money Works

Gynaecology equipment margins depend heavily on where you sit in the chain. A pure distributor typically marks products up 30–50% at gross and nets around 8–12% after logistics, service and overhead — healthy, and notably recession-resistant, because clinics keep operating through downturns. An operator who manufactures or private-labels its own line, or who bundles installation, calibration and repair contracts, can push net margins to 18–30%+. The plan should be explicit about which model you are running, because modelling a distributor's turnover on a manufacturer's margin is one of the most common ways a forecast loses credibility.

There are usually four revenue streams worth modelling separately:

• Capital equipment sales — the big-ticket colposcopes, ultrasound and hysteroscopy systems. High value, lumpy, long sales cycle.
• Consumables & disposables — specula, biopsy kits, electrodes, IUD insertion sets. Lower value, but recurring and predictable.
• Service, calibration & repair contracts — annual maintenance agreements that turn a one-off sale into a multi-year relationship.
• Rental & short-term hire — useful for clinics testing a device or covering a demand spike, and a way to monetise your demo fleet.

A Worked Example

Take a regional distributor turning over $1.6 million in year two at a blended gross margin of 38% and an 11% net margin. That is roughly $176,000 of net profit — before the founder's own drawings are optimised. Now layer in a single capital sale: a robotic-assisted hysteroscopy system at $85,000 with a 42% gross margin contributes about $35,700 of gross profit from one order. Two or three of those a quarter, sitting on top of a steady consumables base, is what a realistic year-two forecast looks like — not a straight line to $10 million. Investors reward the operator who can show the mix, the timing, and the working-capital drag between ordering stock and getting paid by a hospital 60–90 days later.

Market Size, Demand & Growth

The global gynaecological devices market was valued at roughly $10.1 billion in 2023 and is projected to reach $18.1 billion by 2030, a compound annual growth rate of about 8.6%, according to Grand View Research, 2024. A separate estimate from Mordor Intelligence, 2025 puts the market at $11.20 billion in 2025 rising to $16.44 billion by 2030 (7.97% CAGR). The exact figure varies by analyst, but the direction is consistent: mid-to-high single-digit growth for the rest of the decade.

The US is the largest single market, worth about $3.25 billion in 2023 and forecast to reach $5.68 billion by 2030 (Grand View Research). Two structural drivers sit behind the numbers: a rising prevalence of conditions such as endometriosis and infertility, and the shift toward minimally invasive and robotic-assisted procedures, which pulls demand toward higher-value devices.

For an operator, the read-through is straightforward. Surgical and hysteroscopy devices are the biggest pool of spend, diagnostic imaging is where growth is accelerating, and specialist sub-categories such as colposcopy are large enough to build a defensible niche without competing head-on with Hologic or Medtronic across their entire ranges. Regional demand in the UK clusters around London, Manchester and Birmingham, where private women's-health clinics are expanding fastest — a useful anchor for a distributor's first territory.

Who Actually Buys Gynaecology Equipment

One of the reasons generic plans fail in this niche is that they treat "clinics" as a single customer. In reality, gynaecology equipment moves through three distinct buying channels, each with its own budget cycle, decision-maker, and sales motion. Your plan should size each one and be honest about which you can realistically reach first — a distributor that tries to sell to all three at once usually converts none.

• Private women's-health clinics and consultant-led practices. These are the fastest to close. A single consultant gynaecologist often controls the buying decision, values responsiveness and a good demo, and pays on shorter terms than an institution. In the UK this is where the growth clusters — London, Manchester and Birmingham — and it is the natural beachhead for a new distributor.
• Hospitals and NHS trusts (or US hospital systems). The largest orders, but the slowest and most procedural. Purchases run through formal tenders, framework agreements, and annual capital budgets, with 60–90 day payment terms. Winning here usually means getting onto an approved-supplier list first, which the plan should treat as a milestone, not a given.
• Ambulatory surgical centres and fertility clinics. A middle tier — more procedural than a private practice, faster than a trust — and often the sweet spot for hysteroscopy and ultrasound capital sales combined with consumables.

The strongest plans quantify each segment: how many target clinics sit in the launch territory, what the average order value is, how long the sales cycle runs, and what share you expect to win in years one to three. That specificity is what turns a revenue forecast from a wish into something a lender can underwrite. It also forces an honest answer to the question every investor asks — why will a clinic that already buys from Hologic or a national distributor switch to you? The answer is rarely price; it is usually service, availability, or a genuinely underserved local market.

A useful discipline is to write the plan around a single, named priority segment for year one, then show the expansion path into the other two. A distributor that opens by owning private colposcopy clinics in one region, proves the service model, and only then bids for trust frameworks reads as far more credible than one promising national coverage from day one.

Go-to-Market & Launch Timeline

Selling medical devices is a relationship business with a compliance gate in front of it. Your go-to-market plan needs to show both how you reach clinicians and how you clear the regulatory runway in parallel, so that the day registrations complete you already have a pipeline ready to convert rather than starting from cold.

How New Distributors Reach Buyers

• Clinical field reps and demos. Nothing sells a colposcope or hysteroscope like a hands-on demonstration in the clinic. Budget for a demo fleet and the reps to carry it.
• Trade shows and specialist conferences. Events such as women's-health and gynaecology congresses are where dealer relationships and clinic contacts are built in a single week.
• Tender and framework responses. For institutional buyers, a disciplined bid process — and getting listed as an approved supplier — is the whole game.
• Referral and KOL relationships. A respected consultant who trusts your service becomes a reference that shortens every subsequent sale.
• Search and catalogue. Clinicians increasingly research equipment online before contacting a supplier, so a credible catalogue and clear specifications matter more than they used to.

A Realistic First-Year Timeline

• Months 1–2: incorporate, secure premises, begin FDA establishment registration or MHRA registration, and open dealer negotiations with your first one or two manufacturers.
• Months 2–4: finalise dealer agreements, arrange product & professional liability insurance, and build the catalogue and demo fleet.
• Months 3–5: complete state distributor licences (US) or UKCA / UK Responsible Person setup (UK); begin outreach to priority-segment clinics.
• Months 5–8: first capital sales and consumables accounts; start building a service and calibration offer.
• Months 8–12: bid for the first framework or approved-supplier listing; layer in recurring service contracts; open the second territory or product line.

Sequencing matters because cash flows in only after registrations clear and the first demos convert. A plan that shows revenue in month one, before a single licence is granted, tells a lender you have not understood the business. A plan that stages the regulatory work against the sales build tells them you have.

More Questions Buyers Ask

Do you need a licence to sell gynaecology equipment?

Yes. In the US you must register your establishment with the FDA and list every device before commercial distribution, and most states require a wholesale medical-device distributor licence on top. In the UK, devices must be registered with the MHRA and carry UKCA marking. None of this is optional, and all of it belongs in your launch timeline and budget.

What is the difference between a distributor and a manufacturer?

A distributor buys finished, already-cleared devices and resells them, carrying inventory, service and relationships but not design responsibility. A manufacturer designs or private-labels the device and owns the regulatory clearance — the 510(k) in the US, the UKCA/CE conformity assessment in the UK and EU. Manufacturing earns a far higher margin but costs more and takes longer to launch. Most first-time founders start as distributors and integrate backward later.

How much does gynaecology equipment cost to buy wholesale?

It ranges enormously: a box of disposable specula is a few dollars a unit, a video colposcope is $3,000–$18,000, and an ultrasound system with a transvaginal probe can run $12,000–$85,000 at trade prices. Your gross margin comes from the spread between those trade prices and what clinics pay, which is why negotiating dealer terms with the manufacturers listed above matters more than almost anything else.

Is a medical equipment supply business profitable?

It can be. Distribution nets around 8–12%, and the sector is unusually resilient because clinics keep buying through economic cycles. Margins improve materially once you add service contracts, consumables annuities, or your own private-label line. Profitability is a function of your product mix and how well you manage the cash gap between paying suppliers and being paid by hospitals.

Mistakes That Sink New Suppliers

After building plans across the medical-device space, the same avoidable errors show up again and again. Address each one directly in your plan and you will already be ahead of most applicants a lender sees.

• Treating registration as paperwork, not a launch gate. FDA and MHRA timelines dictate when you can invoice. Model them as milestones with dates and fees, not a footnote.
• Under-capitalising demo units. Clinicians buy what they can touch. A sales team with nothing to demonstrate closes nothing; budget a real demo fleet.
• Using a manufacturer's margin on a distributor's revenue. The single fastest way to lose a lender's trust. Pick your model and model it honestly.
• Ignoring the procurement cycle. Hospitals and trusts pay in 60–90 days and buy on annual budgets. A forecast without that cash-flow drag is fiction.
• No recurring revenue. A plan that shows only capital sales looks fragile. Service, calibration and consumables are what make the business bankable.

Operations: Inventory, Service & Logistics

The operations section is where a device business is either believable or not. Two things drive it: inventory management and after-sales service. Handle both well and the business compounds; handle them badly and you tie up cash in stock while clinics quietly switch to a supplier who answers the phone.

Inventory & Sourcing

Gynaecology equipment splits into slow-moving, high-value capital items and fast-moving consumables, and they demand opposite inventory strategies. Capital items — colposcopes, ultrasound systems, hysteroscopy sets — are best held as a small demo fleet and otherwise drop-shipped or ordered against a confirmed sale, because holding six ultrasound units on a shelf ties up six figures of working capital for months. Consumables — specula, biopsy kits, electrodes — should be stocked to a reorder point so a clinic never hears "out of stock", because a stockout on a routine item is how you lose the account that would have bought the next colposcope. The plan should state your reorder policy, your lead times from each manufacturer, and how much working capital sits in inventory at any moment.

Service, Calibration & Repair

This is the quiet engine of a durable device business. A capital sale is a one-off; an annual service and calibration contract turns that same customer into recurring revenue for the life of the equipment, and it is the single strongest reason a clinic sticks with a distributor rather than shopping around. Budget for a biomedical engineer (employed or contracted), spare-parts stock, and calibration equipment, and model service as its own revenue line rather than a cost centre. In practice a mature distributor earns a meaningful share of profit from service, not from the original sale — and lenders love recurring revenue because it makes cash flow predictable.

Compliance in Day-to-Day Operations

Regulation does not stop once you are registered. Ongoing obligations include Unique Device Identification (UDI) traceability, adverse-event reporting (Medical Device Reporting in the US, the equivalent vigilance system under MHRA in the UK), lot and serial tracking, and a documented quality management system. The plan should show these as standing processes with an owner, not as one-time hurdles. A clinic buyer doing due diligence on a new supplier will ask how you handle a device recall — having a clear answer is a competitive advantage.

Building Financials a Lender Will Trust

The fastest way to lose a bank or an equipment financier is a forecast that looks invented. Device distribution has well-understood economics, and a plan that reflects them signals you know the business. A credible financial model for a gynaecology equipment venture should include five things.

• A revenue build from the bottom up. Number of target clinics, expected win rate, average order value, and reorder frequency — not a top-down "1% of an $18 billion market" claim, which lenders discount immediately.
• Separate margin lines for each revenue stream. Capital sales, consumables, and service each carry different gross margins; blending them hides the real economics.
• A working-capital schedule. Show the gap between paying manufacturers and being paid by clinics and trusts (often 60–90 days), because this is where device distributors run out of cash even while profitable on paper.
• A break-even analysis. The month you cover fixed costs, expressed against a realistic ramp — usually somewhere between month 12 and 20 for a distributor building a service annuity.
• A funding request tied to specific uses. "£110,000 for demo fleet and six months of working capital" beats "£110,000 for growth" every time.

A quick sanity check every founder should run: multiply your projected number of active clinic accounts by a conservative average annual spend, and see whether the total lands anywhere near your revenue line. If a forecast needs 300 clinics in year one to work, but your launch territory only contains 40, the model is broken before a lender ever reads it. Our Research + Content and Bespoke packages build this model for you, stress-tested against the ramp a real device distributor achieves rather than the one a spreadsheet wishes for.

Sample Business Plan Preview

Here's an extract from a gynaecology equipment plan written by our team, so you can see the level of detail you'll get:

What's Inside the Template

Every Avvale business plan template comes pre-structured for your industry, so you fill in specifics rather than staring at a blank page:

• Executive Summary — your device business at a glance, written to hold a lender's attention in the first minute.
• Company Overview — legal structure, ownership, whether you are distributing or manufacturing, and your founding story.
• Industry Analysis — market size, growth, and the regulatory environment specific to gynaecology devices.
• Customer Analysis — private clinics, hospital procurement, and consultant gynaecologists, and how each one buys.
• Competitor Analysis — where you sit against Hologic, CooperSurgical, Karl Storz and regional distributors.
• Marketing & Sales Plan — trade shows, clinical reps, tender responses, and referral channels.
• Operations Plan — sourcing, inventory, service logistics, calibration and repair workflows.
• Management Team — founder credentials, clinical advisors, and key hires such as a biomedical engineer.

The optional Financial Forecast add-on (included in the $300/£250 and $1,000/£800 packages) provides a five-year Excel model with income statement, cash flow, balance sheet, break-even analysis, and startup-capital requirements — the exact documents an SBA lender or bank asks for. If you'd rather not build it yourself, our business plan writers can do the whole thing, and you can compare neighbouring niches such as the medical equipment business plan template, the gynecology surgical instrument plan, or the durable medical equipment plan to see how the structure adapts.

Frequently Asked Questions